Featured Opinions
Ms the word: What I learned by disabling skype
*Want to devise a better marketing campaign? Shut up and listen.*
M's the word: Does pharma need more heroes?
Instead of avoiding PR disasters, it's about time we started talking about the fantastic achievements of the industry.
Mal's musings: Bring on the competition!
The marketing team is running around in panic, projections are being reviewed, and sales force strategy abandoned. Why?
Ms the word: Get off the phone and check your cholesterol
*Why are we willing to pay more for our cellphones than for our health insurance?*
Hey, this is pharma marketing. This is about making lives better. So get off Twitter and treat it seriously!
Mals Musings: Its time for pharma to get serious about CSR
Why future success should be measured by gains in corporate social responsibility (CSR) as well as in share price
Mals Musings: Sales force effectiveness 2.0
To make SFE relevant again, we need to start adding value rather than extracting it.
Can chief marketing officers (CMOs) really make marketing relevant again?
Southwest Airlines and Pharma Content Creation: Whats the Connection?
by Sam Agris
I spend a fair amount of time on airplanes for business and some for pleasure and always try to take the nonstop flight to my destination.
What consumers want in DTC ads
A group of consumer, senior, patient safety organizations and small insurers, including Community Catalyst and various state public interest research groups, filed their own comments with the FDA o
An excellent article written [1] by Dr Bernie Siegel today; "I recently received two emails: one from a woman who had a recurrence of her cancer and has decided to not undergo chemotherapy again. Her doctor said, "Then you might as well go home and commit suicide." [1] http://www.huffingtonpost.com/bernie-siegel-md/health-care-advice-the-po_b_621161.html
Some stats on healthcare marketing
An overwhelming majority of respondents(physicians, 91%) reported believing that physicians order more diagnostic tests and procedures than are needed in order to protect themselves from malpractic
Now that we have wrapped up a year's worth of research I asked my client if I could release some of the top level findings from research and they agreed.
Using transparency as the means to restore patient trust
In response to the current concerns, I suggest that Glaxo and the FDA work together, using transparency as the means to restore patient trust and to support the effort to make the right decisions.
Mals Musings: Whats Up with The Bottom Line?
Upon reflection, there are a number of misconceptions in business and many more ideas, concepts, and scenarios better categorized as bullsh_t.
Since this is the first of this series, I'd welcome any comments and feedback. How do you think the industry will develop? And how do you think companies should adapt to these changes?
Mals Musings: Segmentation, Segmentation, Segmentation
Customers differ! They differ in characteristics, needs, and the way they respond to our value propositions.
Mals Musings: Mind Marketings Rhetoric-Reality Gap!
No profession suffers amateurs and pretenders like marketing. In many ways, the function is at a crossroads, since the gap between rhetoric and reality is glaring.
Mals Musings: SWOTTime for a Product Recall
The SWOT must be the most popular strategy-making tool in the world. You are unlikely to come across anyone involved in the business world that will not know this tool.
Mals Musings: Is Your Value Proposition Unique?
Every business manager is obsessed by a desire to deliver a unique value proposition, the kind of proposition that customers just cannot resist.